Lexeo Therapeutics, Inc.
LXEO
$5.09
-$0.41-7.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 193.04M | 181.77M | 122.76M | 132.89M | 99.83M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.82M | 6.63M | 5.03M | 7.17M | 5.44M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 200.86M | 188.39M | 127.79M | 140.06M | 105.27M |
|
|
|||||
| Total Current Assets | 200.86M | 188.39M | 127.79M | 140.06M | 105.27M |
| Net Property, Plant & Equipment | 8.35M | 8.86M | 9.41M | 9.76M | 10.13M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M |
| Total Assets | 250.36M | 268.69M | 143.84M | 176.07M | 125.69M |
|
|
|||||
| Total Accounts Payable | 3.34M | 4.86M | 4.66M | 20.03M | 11.98M |
| Total Accrued Expenses | 8.06M | 9.20M | 9.69M | 8.73M | 15.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.70M | 2.68M | 2.72M | 2.66M | 2.65M |
| Total Finance Division Other Current Liabilities | 103.00K | 73.00K | 209.00K | 186.00K | 669.00K |
| Total Other Current Liabilities | 103.00K | 73.00K | 209.00K | 186.00K | 669.00K |
| Total Current Liabilities | 14.19M | 16.81M | 17.27M | 31.59M | 30.82M |
|
|
|||||
| Total Current Liabilities | 14.19M | 16.81M | 17.27M | 31.59M | 30.82M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.67M | 5.21M | 5.74M | 6.26M | 6.75M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.86M | 22.02M | 23.01M | 37.85M | 37.58M |
|
|
|||||
| Common Stock & APIC | 631.99M | 626.63M | 479.97M | 477.18M | 401.02M |
| Retained Earnings | -400.33M | -380.13M | -359.22M | -338.93M | -312.83M |
| Treasury Stock & Other | -159.00K | 171.00K | 72.00K | -30.00K | -71.00K |
| Total Common Equity | 231.50M | 246.67M | 120.83M | 138.22M | 88.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 231.50M | 246.67M | 120.83M | 138.22M | 88.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 231.50M | 246.67M | 120.83M | 138.22M | 88.12M |
|
|
|||||